Cargando…
Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
The N-glycolylated ganglioside NeuGc-GM3 has been described in solid tumors such as breast carcinoma, nonsmall cell lung cancer, and melanoma, but is usually not detected in normal human cells. Our aim was to evaluate the presence of NeuGc-GM3 in pediatric neuroectodermal tumors by immunohistochemis...
Autores principales: | Scursoni, Alejandra M., Galluzzo, Laura, Camarero, Sandra, Lopez, Jessica, Lubieniecki, Fabiana, Sampor, Claudia, Segatori, Valeria I., Gabri, Mariano R., Alonso, Daniel F., Chantada, Guillermo, de Dávila, María Teresa G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177098/ https://www.ncbi.nlm.nih.gov/pubmed/21941577 http://dx.doi.org/10.1155/2011/245181 |
Ejemplares similares
-
Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas
por: Pilco-Janeta, Daniel, et al.
Publicado: (2019) -
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
por: Segatori, Valeria I., et al.
Publicado: (2012) -
Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin
por: Blanco, Rancés, et al.
Publicado: (2013) -
Aberrant O-glycosylation modulates aggressiveness in neuroblastoma
por: Cuello, Hector A., et al.
Publicado: (2018) -
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data
por: Vázquez, Ana M., et al.
Publicado: (2012)